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ABSTRACT 
 
Paul G. James:  Beryllium, an Environmental Exposure Factor as Cause for Reconsidering 
Sarcoidosis Diagnoses  
(under the direction of Woodhall Stopford) 
 
 
 Several years ago a cluster of sarcoidosis cases occurred in a neighborhood in the 
southwestern part of North Carolina.  The neighborhood was located near a large beryllium 
reserve and a few miles away from a quarry in which one of the sarcoidosis patients was 
employed.  Background information included the facts that gravel from the local mine(s) had 
been used on some of the neighborhood roads prior to the time roads were paved, and that there 
was also agricultural activity in the area.  Considering that these sarcoidosis cases were in a 
residential neighborhood, the proximity of quarries to the neighborhood, the large beryllium 
reserve in the area, and the fact that one of the sarcoidosis patients was employed at the quarry 
led to the question of whether chronic beryllium disease (berylliosis) due to an environmental 
exposure should be considered as a diagnosis for these individuals instead of sarcoidosis.  
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CHAPTER 1:  INTRODUCTION 
 Beryllium is a naturally occurring element which is present in rocks, coal, oil, soil, and 
volcanic dust, and it is also the lightest metal.(ATSDR, 2002) It is a silver-gray to grayish-white 
Group II metallic element with an atomic weight of 9.01 which is lighter than aluminum, but 
40% more rigid, and about one-third more elastic than steel.(DHHS, 2005) It is present at about 
6mg/kg in the earth’s crust and at 0.03-0.06 ng/m3 in the atmosphere in rural areas of the 
US.(WHO, 1990) The source of the largest amount of naturally occurring atmospheric beryllium 
and beryllium compounds is windblown dust, 5 metric tons/year, and the largest anthropogenic 
sources are electric utilities, 3.5 metric tons/year.(DHHS, 2005)  The most common form for 
naturally occurring beryllium is the beryllium aluminum silicate (beryl), 
3BeO
.
Al2O3
.
6SiO2.(Cooper & Harrison, 2009) 
 Beryllium is critical to nuclear, aerospace, and electronics industries among 
others.(Kreiss, et al., 2007) Its value, in addition to being a light metal with a high melting point, 
is that when used as an alloy it increases thermal and electrical conductivity and strength. 
(DHHS, 2005; IARC, 1993)  In addition, beryllium has a high affinity for oxygen which allows 
its surface films to provide high resistance to corrosion, water, and cold oxidizing acids.(WHO, 
1990)   The most commonly used beryllium products are beryllium-copper alloys though 
beryllium-aluminum alloys containing up to 65% beryllium are becoming more 
important.(McNeil, 2001)  The strength of copper is increased 6-fold by the addition of 2%  
beryllium.(Cooper & Harrison, 2009)(IARC, 1993)
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DISTRIBUTION AND MINING 
 Most beryllium mining in the United States is carried out in the Topaz-Spor Mountains in 
Utah and most of the beryllium manufacturing is done by Brush Wellman in Ohio. (Brush 
Wellman)  A recent business article states that the mine site in Utah produces 80,000 tons of 
bertrandite ore annually.(Rattle, 2007) Bertrandite is one of two economically important 
beryllium minerals, notwithstanding the gemstones emerald and aquamarine, and it contains less 
than 1% beryllium.(WHO, 1990) Beryl is the other mineral and it can have as much as 4% 
beryllium (Ibid). It is thought that “shallow epithermal environments” such as the one at the Utah 
site are favorable for the deposition of beryllium.(Lindsey, 1977) Through the year 2004 the US 
was producing about 80% of the world’s beryllium output with China, Brazil, and Mozambique 
providing most of the remainder.(McNeil,D. ) 
 As might be expected, beryllium levels in soil vary from place to place.  Overall, 
beryllium in soils is found at levels of 0.1-40 mg/kg.(Sutton, et al., 2012; Taylor et al., 2003; 
Anderson, et al., 1990; Shireman, Mayila, et al., 1995) The beryllium at 3 sites in the 
southeastern US was measured at levels as high as 17.8 mg/kg, but the mean level was only 
0.15mg/kg.(Sutton, et al., 2012; Aelion, et al., 2009) 
BERYLLIUM TOXICOLOGY 
 Beryllium can cause both acute and chronic health problems, usually from breathing 
beryllium mists, dusts, or fumes.(DOE) It has been known since the 1930’s that beryllium was a 
lung hazard, and it was subsequently found that chronic lung disease developed in beryllium 
manufacturer workers and other workers exposed to beryllium materials.(Kreiss et al., 2007;⁠ 
Gelman, 1936; Hardy & Tabershaw, 1946)  For the purposes of the Department of Energy, 
regulation 10 CFR 850 of the Chronic Beryllium Disease Prevention Program defines beryllium 
as: “elemental beryllium and any insoluble beryllium compound or alloy containing 0.1 percent 
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beryllium or greater that may be released as an airborne particle”.(DOE)  
 Beryllium sensitization among workers is estimated at 1-16% Saltini et al., 2001) and 
approximately 50% of beryllium sensitized individuals already have chronic beryllium disease 
upon clinical examination.(Newman, et. al., 2005)  The progression of beryllium sensitization 
(BeS) to CBD is 6 to 8% per year after the initial diagnosis.  One estimate that is now several 
years old is that up to 800,000 workers in the U.S. have already been exposed to beryllium 
(Barna, et al., 2003), so there could potentially be a large number of affected individuals. The 
addition of a 2µg/m
3
 standard in 1948, which was accepted by the Atomic Energy Commission 
in 1949 and by OSHA in 1971, was considered important, but in 1998 the OSHA Assistant 
Secretary admitted that a 2 µg/m
3
 PEL did not protect beryllium exposed workers from 
developing chronic beryllium disease.(Michaels & Monforton, 2008) 
 The basis of the initial beryllium standard was not epidemiological findings, rather it was 
based on the atomic weight of beryllium compared to other toxic metals. (Kreiss et al., 2007; 
Eisenbud, 1982; Eisenbud, 1998)  NIOSH has established a workplace air advisory of 0.5µg/m
3
 
10hr TWA, OSHA has a 2µg/m
3
regulation for PEL as TWA and 5µg/m
3
 ceiling, and there are 
other agency regulations as well.(ATSDR, 2008) Brush Wellman uses a 0.2 µg/m
3
 per 8 hour 
time weighted average standard.(Carey, 2005) 
 Acute beryllium disease in which beryllium acts as chemical irritant, as thought by some, 
is no longer very common due to the industrial efforts to improve safety, though chronic 
beryllium disease (CBD) continues to occur.(Dweik, 2008) There are some; however, who think 
that the dermatitis associated with acute beryllium disease is not due to irritative effects, but 
instead may be a result of delayed-type hypersensitivity, and that acute beryllium disease may, 
like chronic beryllium disease, be immune-mediated. (Cummings, et al., 2009)  According to 
Dweik, the pathogenesis of CBD proceeds as a delayed-type hypersensitivity reaction with 
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beryllium acting as a hapten and a class II restricted antigen.(Dweik, 2008) It has been described 
as a “progressive, noncaseating granulomatous disease of the lung” which can cause 
death.(Haley, 1991)  It has been reported that the soluble forms of beryllium are the most likely 
culprits for sensitization and could occur by respiratory, dermal, or oral routes of 
exposure.(Deubner et al., 2001) The same authors report that CBD is most often associated with 
beryllium oxide, but it was unknown whether this was due to chemical properties or due to its 
tendency to form small particles (0.1um) during manufacturing.  The same was true for 
beryllium metal which had the second most common association with CBD. 
 It has been suggested that the low prevalence of chronic beryllium disease may be due to 
genetics, and immunogenetic research has shown support for this concept. (Haley, 1991), 
(Lombardi et al., 2001) HLA DP presents beryllium to lung-derived CD4+ T cells from CBD 
patients, and this appears to be a selective ability when compared to HLA DR and HLA 
DQ.(Fontenot, et al., 2000)  HLA DP Glu69 has been found to be associated with berylliosis, and 
its gene has been shown to have a role in the disease pathogenesis.(Saltini, et al., 1998)  
However, the high prevalence of this HLA type in the population and the low prevalence of 
Chronic Beryllium Disease means that it has poor positive predictive value.(Kreiss et al., 2007) 
 One of the diagnostic tools available for the diagnosis of CBD is the beryllium 
lymphocyte proliferation test (BeLPT), and it can be used to detect beryllium sensitization prior 
to pulmonary disease.(Middleton & Kowalski, 2010) In this test, beryllium sulfate is used to 
stimulate sensitized T-lymphocyte uptake of tritiated thymidine and then compared to T cells not 
artificially exposed to beryllium sulfate.  The BeLPT is used to help distinguish chronic 
beryllium disease from sarcoidosis.(Maier, 2002) 
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OBJECTIVES 
1. Provide a literature review of beryllium and chronic beryllium disease (berylliosis) 
2. Provide sufficient information about sarcoidosis that it can be compared to berylliosis 
3. Discuss a cluster of sarcoidosis cases which occurred in Cleveland county, North Carolina 
4. Discuss environmental beryllium in the context as to whether it could have played a role in 
the cluster of cases and and whether sarcoidosis in the cluster cases could be a misdiagnosis 
5. Discuss future research activities for beryllium 
BACKGROUND:  
SARCOIDOSIS AND BERYLLIOSIS 
 Sarcoidosis is a multisystem granulomatous disease which was first identified in 
1899.(Iannuzzi & Fontana, 2011) Noncaseating granulomas without organisms or particles is 
characteristic of sarcoidosis, but there is no single diagnostic test for sarcoidosis. This disorder is 
most prevalent in northern Europe at an incidence of 5 to 40 cases per 100,000 people , but exists 
in many countries.(Iannuzzi,et al., 2007)  Sarcoidosis associations with HLA  Class II genes 
differ with cohort, ethnicity, and race. (Spagnola & du Bois, 2007)  In the US sarcoidosis affects 
black individuals approximately 3 times more often than whites and is also more likely to be 
fatal and chronic in black individuals. (Iannuzzi et al., 2007; Rybicki et al., 1997)  Peak 
incidence usually occurs between the ages of 20 and 39 although the peak for black Americans 
will be their 40's. Sarcoidosis has an unknown etiology but these authors suggest that much 
consideration is being given to environmental exposure to airborne antigen due to the lung, eye, 
and skin involvement.  Heffner argues that sarcoidosis has as a cofactor a genetic-based 
dysregulated hyperimmune response that operates along with its other cofactor, the presence of 
noninfectious, common, mineral nanoparticles to cause disease.(Heffner, 2007) 
 The difficulty in distinguishing sarcoidosis from berylliosis can be seen from a 
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prospective case study in which upon re-evaluation, 34 of 84 sarcoidosis patients were diagnosed 
with chronic beryllium disease.(Muller-Quernheim, et al., 2006)  In this study the authors used 
the Beryllium Lymphocyte Proliferation Test, occupational history, and upon finding positive 
BeLPTs, furthered support of their diagnosis of CBD with an occupational evaluation of the 
workplaces. The difficulty in distinguishing beryllosis from sarcoidosis by laboratory or clinical 
analyses can be seen in Figure 1 which uses data derived from published tabulated data of 
Carrington et al.(Carrington et al., 1976) 
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Figure 1: Berylliosis and Sarcoidosis Comparison; data from Carrington et al. used with 
permission from John Wiley and Sons;(Carrington et al., 2006) (top left, findings based on 
physiology; top right, radiology findings; bottom left, histology findings; and bottom right, 
granuloma composition; plotted using R(RCoreTeam, 2013)  
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BERYLLIUM AND CANCER 
 Beryllium is listed as a Group 1 carcinogen by IARC, i.e. probably carcinogenic to 
humans, and IARC also concluded evidence of carcinogenicity was sufficient for 
animals .(Beyersmann & Hartwig, 2008; IARC, 1993) It has been categorized as a “known 
human carcinogen” since 2002 by the National Toxicology Program (NTP, 2011) due in part to 
epidemiological studies which indicate there is an increased risk of occupational lung disease 
when working with beryllium.(Steenland & Ward, 1991) One of the possible causalities for 
carcinogenesis is infidelity of DNA replication(NTP, 2011; Leonard & Lauwerys, 1987).  
Beryllium competes with Mg
2+
 for nucleic acid phosphate binding sites, it activates mitogenic 
signaling pathways(Beyersmann & Hartwig, 2008; Misra, et al., 2002), it induces the expression 
of proto-oncogenes in vitro(Beyersmann & Hartwig, 2008; Kesheva et al., 2001), and it induces 
hypermethylation of DNA for a tumor suppressor gene which results in less gene 
product(Beyersmann & Hartwig, 2008), (Belinsky et al., 2002). Studies have shown that 
beryllium salts are not mutagenic in bacteria, but studies have also shown that beryllium salts 
affect chromosomes and cause mutations in mammalian cells.(Steenland & Ward, 1991; Gordon 
& Bowser, 2003) Lung cancer has also been found by some to be strongly correlated to mean, 
maximum, and cumulative beryllium exposures for male workers in beryllium processing 
plants.(Schubauer-Berigan, et al., 2011)  
 However, a literature-based weight of evidence study for beryllium as a cause of lung 
cancer concluded, using Bradford Hill criteria(Hill, 1965), that the carcinogenicity of beryllium 
in humans should be considered either inadequate or marginally suggestive.(Hollins et al., 2009) 
The authors of the weight of evidence study attribute some of the lung cancer cases to very high 
doses of beryllium that are no longer typical of industrial exposures.  
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BERYLLIUM CLEARANCE 
 Mucociliary escalator transport, translocation to tracheobronchial lymph nodes, alveolar 
macrophage clearance to the tracheal region, and solubilization of beryllium are mechanisms 
which may contribute to the clearance of beryllium.(EPA, 1998) Generally, phagocytosis is a 
rapid process with 50-70% of particles engulfed by the macrophage within 2-3 hours and 
approximately 100% internalization after 24 hours.(Geiser, 2010) However, phagocytosis of 
inhaled nanoparticles only occurs at a rate of approximately 0.1% per 24 hours and appears to 
occur sporadically. Nanoparticles in the lung are cleared primarily by movement up the 
respiratory tree via mucociliary transport, but the macrophages can also transport the particles 
from alveolar epithelium to the interstitium or to the circulating blood.(Ng, et al., 2004)  Contact 
of the insoluble particles with epithelial cells followed by uptake into underlying cells is likely to 
occur if the particles have escaped elimination by the mucociliary escalator or by the 
alveolar/airway macrophages.(Churg, 1996; Adamson & Bowden, 1981) The skeleton is the 
ultimate beryllium storage site following its clearance from the lungs although clearance from 
the lung to the tracheobroncial lymph nodes or to liver,kidney, spleen or other tissues will 
occur.(Muller et al., 2010; Finch et al., 1990)  
BERYLLIUM SOLUBILITY 
 Dissolution rates in phagolysosomal simulant fluid were determined to have rate 
constants on the order of 10
-8
 g/cm
2
-day for beryllium oxide, and 10
-7
g/cm
2
-day for beryllium. 
(Stefaniak, et al. , 2006) These rate constants were independent of the initial mass and provide 
insight into the amount of dissolved beryllium that macrophage lysosomes may produce.  Beryl 
ore dusts emitted from a heat-treater, in which the silicate structure has been destroyed, have 
dissolution rates of approximately 1 x 10
-8
 g/cm
2
-day, and the beryllium hydroxide powder has a 
rate of approximately 2 x 10
-7
 g/cm
2
-day.  
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 A dissolution rate of 7.8 x 10
-5
 of the initial amount of added beryllium was obtained after 
approximately 30 hours (constant rate achieved) by passing a serum ultrafiltrate simulant over 
beryllium particles.(Andre et al., 1987) In vivo beryllium solubility rates in baboons and rats 
following intratracheal injection were 5 x 10
-6
 for metal and 5 x 10
-5
 for hot-pressed particles. 
When poorly soluble particulate beryllium compounds were assessed for solubility in artificial 
macrophage phagolysosomal fluid, it was found that the beryllium materials associated with 
elevated disease levels had faster dissolution rates than beryllium materials which were not 
associated with higher disease levels (p<0.05).(Stefaniak et al., 2011a) 
 By comparison to another material, plasma solubilized approximately 0.48% of the 
available silica from 5 µm quartz dust particles over 8 days(243 µg from 50 mg), and 
approximately the same amount was solubilized with serum (233 µg).(Rahman et al. , 1975) This 
gives a rate of approximately 3.0 x 10
-5
g silica solubilized/day or 1.2 x 10
-6
 g/cm
2
-day. The Ka 
which defines the dissociation of SiOH to SiO- H+ at 25 °C is 10
-6.8
. (Dove, 1994; Schindler & 
Kamber, 1968) 
 Particles larger than 5-10 µm in the lung will be cleared by the mucociliary escalator and 
phagocytosis, and soluble beryllium is cleared by dissolution in the pulmonary 
fluid.(Paustenbach et al., 2001; McClellan & Henderson, 1995)  Inhaled water-soluble beryllium 
salts are primarily excreted via the kidneys with a half-life of 2-8 weeks.(Muller et al., 2010; 
Zorn et al., 1986) Intracellular solubility following phagocytosis is another potential toxicity 
issue.(Finch et al., 1988) 
 Some studies report that absorption through intact skin is negligible although injured skin 
could be vulnerable to higher absorption. ( Deubner et al., 2001; Ivannikov et al., 1982) Other 
studies have indicated that skin exposure to soluble beryllium salts is a cause of systemic 
immunological sensitization.(Stefaniak et al., 2011b; Zissu et al., 1996) Rates of beryllium 
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dissolution in sweat are ~1.2 x10
-9
 g/cm
2
-day at pH 5.3 and 5.3 x 10
-11
 g/cm
2
-day at pH 
6.5.(Duling et al., 2012)  
 Ingestion is not the major route for beryllium exposure, but long ago the U.S. Public 
Health service set a value of 0.006% for gastrointestinal absorption though other research only 
suggests a general level of <1%.(Deubner et al., 2001) 
BERYLLIUM EXPOSURE 
 A comparison of personal breathing zone samplers obtained over a four year span 
revealed that bertranidite foot miners had one of the lower overall beryllium 
exposures(0.07µg/m
3
) among mining processes while workers involved in loading, crushing, and 
grinding bertrandite ore had levels of exposure 0.55 µg/m
3
, beryl furnace workers 0.64 µg/m
3
, 
furnace pour, heat treat, grinding workers 0.99 µg/m
3
 and those involved in the precipitation and 
drumming of Be(OH)2 0.76 µg/m
3
.(Deubner et al., 2011) A separate study of different work 
process areas such as crushing, melting, heat treating, grinding, and drumming showed that 
particles had specific surface areas ranging from 0.34-25.87 m
2
/g. The smallest particle surface 
areas were associated with drumming (0.34-0.4 m
2
/g), grinding (beryl) work areas had surface 
areas of 4.32-6.41 m
2
/g, heat treating 8.94 m
2
/g, melting 7.14-13.39 m
2
/g, and crushing (beryl) 
7.03-25.87 m
2
/g.(Stefaniak et al., 2008) 
          Exposure estimates from beryllium workdays include hand to mouth, tracheobronchial 
mucociliary-aided ingestion, and head airways ingestion with a total ingestion estimate of 
0.0365-4.11 µg/ day and an inhalation estimate of 0.116-1.63 µg/day.(Deubner et al., 2001)  
 The temperature at which beryllium oxide is calcined is a factor in its toxicity, and 
attributes such as particle size or surface area and solubility of the beryllium oxide may be 
contributing factors to the toxicity.(EPA, 1998; Finch, et al., 1988) Beryllium oxide calcined at 
500 ˚C is reported to be more toxic than that calcined at 1000 ˚C and this difference may be due 
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to the greater surface area of the 500 ˚C BeO. 
INSTRUMENTAL METHODS FOR TISSUE DETECTION OF METALS IN TISSUES 
 An analytical method which can be used for the quantitative detection of metals in 
formalin-fixed paraffin-embedded tissue is high resolution inductively coupled plasma mass-
spectrometry (ICP-MS). (Sarafanov et al., 2008)  Metals Fe, Zn, Se, and Cd were measured in 
tissues following deparaffinization by machine based xylene for one week at 55 °C or by 
handling based deparaffinization by hexane at 20 °C for one week.  The quantitative recovery of 
the metals ranged from 24-97%.  
 A separate study compared Cu, Fe, and Zn levels of fresh, frozen, and paraffin embedded 
bovine liver samples by ICP. (Bischoff, et al., 2008) A higher value for the metals was 
consistently found in the paraffin embedded samples and the authors found this difficult to 
explain.  Their overall view was that results obtained from formalin-fixed samples with or 
without paraffin embedding were useful but should be interpreted with caution and that fresh or 
frozen samples were preferred.  
 Flame atomic absorption has also been used as a detection system to compare metal 
quantities in tissues which had been deparaffinized versus levels in fresh frozen 
tissues.(Johnston, et al., 2009)   The findings for canine liver levels of Cu, Fe, and Zn revealed 
that while there were differences between fresh frozen tissue and deparaffinized tissue there were 
no changes in the clinical severity scoring based which typically included a broad range of 
concentration values for each severity level.  
 Laser ablation ICP-MS typically uses cryo cut native samples with sample sizes ranging 
from 1 square mm to 100 mm x 100 mm with thicknesses of 10-100 micrometers. (Becker, 2013) 
The technique has sensitivities in the range of 0.001-1 ug/g, it can support simultaneous scanning 
of up to 40 elements, and it can be used to image samples such as a brain hemisphere.   
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BERYLLIUM DETERMINATION IN LUNG TISSUE OF A  
NUCLEAR WEAPONS WORKER 
 
 Beryllium has been detected in the human lung tissue of a female with occupational 
exposure to beryllium at a nuclear weapons testing facility.(Butnor et al., 2003)  Local areas of 
beryllium in the tissue could be identified by negative backscattered electron imaging (BEI) in 
which the beryllium had a light appearance against a dark background. Confirmation of the 
substance as beryllium was accomplished using paraffin sections of lung tissue and the 
nondestructive technique of atmospheric thin-window energy-dispersive X-ray analysis (ATW 
EDXA) which generated a spectrum with discrete beryllium peaks.  
 This case study patient's medical history revealed she had already developed a cough with 
dyspnea on exertion, and biopsy revealed nonnecrotizing, granulomatous inflammation. The 
occupational history, biopsy, positive beryllium lymphocyte proliferation test, and the presence 
of beryllium in the lungs are major factors which can support a diagnosis of berylliosis. The 
ATW EDXA technique provided confirmation that beryllium was present in lung tissues and thus 
helped provide diagnostic distinction between sarcoidosis and berylliosis that histology and 
clinical testing alone did not provide.  
HISTORICAL LEVELS OF BERYLLIUM DETECTION DUE TO ACUTE, 
OCCUPATIONAL, AND NONOCCUPATIONAL EXPOSURES 
 
 An older study that looked at tissue, urine, sputum, and blood samples from individuals 
with beryllium exposure had several findings in the tissue samples of the study subjects. (Dutra, 
et al., 1949) They measured 9-220 ug beryllium per 100 g lung tissue in subjects with acute 
beryllium disease, 1.7-78 ug per 100 g lung tissue for subjects with chronic disease and 
occupational exposure, and in 3 of 4 non occupationally exposed individuals with chronic 
disease they found 0.24-1.6 ug beryllium per 100 g lung tissue.  Beryllium was also detected in 
kidney stones of the subjects.  
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WORK SITE EXPOSURES TO BERYLLIUM CONTINUE 
Work sites continue to be a source of numerous cases of chronic beryllium disease.  For 
instance the Y-12 national lab in Tennessee had 17 active workers with chronic beryllium disease 
in the year 2007 and 40 additional workers had tested positive for beryllium sensitization at that 
time. (Munger, 2007)   Even OSHA inspectors have been vulnerable with 10 of its 271 inspectors 
sensitized to beryllium. (Carey, 2005) 
COMMUNITY ACQUIRED CHRONIC BERYLLIUM DISEASE 
 Though no new cases of community-acquired chronic beryllium disease (CA-CBD) have 
been reported since 1969, a more recent (2008) journal article takes a look back at the 
occurrences near the Lorraine, Ohio and Reading, Pennsylvania beryllium facilities. (Maier,et al., 
2008)  During the early years of operation in Lorraine, Ohio the community based rates of CBD 
were similar those found in the beryllium plant so it was considered that airborne particles could 
be responsible. In Ohio all  but one case occurred in residents living within 0.75 mile radius of 
the plant, but in Reading, Pennsylvania the cases were found up to 5.3 miles from the plant. In 
this publication, the authors report on their reexamination of some of the patients in the Reading 
area and also on additional people from that area that came forward.  
 They found 8 cases to investigate with confirmed CBD in five cases and three probable 
cases. Their study excluded individuals with occupational or para-occupational exposure , i.e. 
exposure of family members to workplace chemicals via dust  in worker's clothes, shoes, 
hair.(Donovan et al., 2012) In contrast to the study done many years earlier in which affected 
residents lived as far as 5.3 miles away with over half living over 4 miles away from the 
beryllium facility, the patients in this study( diagnosed between1999 and 2002) lived within 1.5 
miles from the plant and were not in the path of the prevailing wind for the area. Three of the 
cases were family members suggesting genetic susceptibility. 
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 There have been few, if any, other recently published studies of this nature; however, this 
paper has indicated that new cases community acquired cases have not been reported since 1969 
and so it would appear that the safety at the beryllium plants has improved.  
 The study described above did not include para-occupational beryllium exposures.  In the 
earlier industrial years however,  para-occupational exposures were known to occur as in the 
finding for 60 neighborhood cases in which the beryllium exposure for 27 of the cases was only 
through contaminated clothing. (Knishkowy & Baker, 1986);Hardy, et al., 1967)  One study 
showed that shaking clothes contaminated with beryllium released an average of 500 µg 
beryllium/m
3
 air.(Knishkowy & Baker, 1986);Eisenbud, et al., 1949) 
SARCOIDOSIS FALL LINE AND NORTH CAROLINA         
Sarcoidosis, especially sarcoidosis in the U.S. south was a topic for discussion even in the 
aftermath of World War II.  A study from that era with members of the Armed Forces who had 
been diagnosed with sarcoidosis used birthplace and sarcoidosis induction residence as part of 
discussion which makes an argument for soil composition as a contributing factor for 
sarcoidosis.(Gentry et al., 1955)  From the cases they developed a fall line which ran from mid 
Texas up through Arkansas, the western part of Kentucky and Tennessee before dipping back 
down into Alabama and Georgia and up through the middle of North Carolina and Virginia and 
which demarcated a preponderance of cases most of which occurred below the line. The Middle 
Atlantic Coastal plain was one of the areas described by the authors and, it was associated in part 
with Red-Yellow Podzolic soils which were present in many states, but the North Carolina black 
service men had a particularly high sarcoidosis rate of 71.3 cases per 100,000 in that soil region.  
Based on the study group, the black population was generally far more prone to sarcoidosis than 
whites no matter where they had lived. 
In addition to soil, a number of possible vectors are mentioned as possible etiological 
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factors for sarcoidosis, and the similarity of sarcoidosis to berylliosis brought in possible 
associations with beryllium and beryllium/soil composition.  The soils of the Middle Atlantic 
Coastal Plain were said to be derived from granitic rock in the Appalachians which they 
described as having the major concentration of beryllium surface ore in the U.S. 
ROLE OF STATE HEALTH DEPARTMENTS IN SUSPECTED DISEASE CLUSTERS 
 State Health Departments may have many cluster investigation requests, but typically 
only 1-3% of these requests result in field investigations. (Wartenberg & Greenberg, 1992; 
Greenberg & Wartenberg, 1991)   From the Health Department's point of view, their resources 
are limited, and epidemiologists have concerns that data provided by residents are biased, usually 
not worthy of scientific follow-up and usually don't help health officials find true problems.  
  A finding in a 1991 report was that reporting of disease clusters was stretching health 
departments resources and not revealing many environmental hazards, and it was the opinion of 
the authors that cluster investigations were actually biased away from the most serious 
hazards.(Wartenberg & Greenberg, 1992)  A survey of state health departments showed that from 
those health departments which responded, a noncommunicable cluster investigation was likely 
to originate from citizen reports (37 states), politician requests (33 states), news articles/media 
reports (30 states), tracking data (28 states), and physician or health care providers (17 
states).(Juzych et al., 2007)  
 A protocol for investigating disease clusters was developed and published by Wisconsin 
public health workers.(Fiore, et al., 1990)   It includes the following 8 steps: "1) circumscribing 
the cluster; 2) ascertaining cases; 3) assessing risk of exposed versus a referent population; (4) 
statistically analyzing disease rates; 5) examining potential exposure; 6) assessing biologic 
plausibility; 7) determining cluster significance and need for further investigation; and (8) 
reporting results."  This Wisconsin health group did not view the investigation as a purely 
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scientific endeavor, but viewed it as part of an important interactive public health activity.
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CHAPTER 2:  BERYLLIOSIS AND SARCOIDOSIS IN NORTH CAROLINA  
SARCOIDOSIS CLUSTER 
 NC Department of Health and Human Services, Division of Public Health contacts (Dr 
Ricky Langley and Amy Stopford (former intern)) have provided unpublished information 
regarding a sarcoidosis cluster in Cleveland County, in the western part of North Carolina.  The 
Centers for Disease Control (CDC) forwarded information regarding these cases to NC Division 
of Public Health after they were contacted by one of the affected residents. There were 9 cases in 
a neighborhood, and a focus on five of these individuals provided the following profile: they 
were all black, 3 females, 2 males, sarcoidosis was confirmed by biopsy in all five cases, and the 
five individuals included a mother-son and a husband-wife pair.  At the time of diagnosis one 
person was employed as a mechanic at the Foote Mineral Company, one was a truck driver, and 
3 were in the school system.  The neighborhood which was affected included 6 households and 
was located approximately 2 miles from the Kings Mountain Mica Patterson Plant and 
approximately 5 miles from Martin Marietta Aggregates (gravel) and Rockwood Lithium Mine.  
 The Kings Mountain Region contains a large beryllium reserve (Bentzen, 1970).  One of 
the components is a “tin-spodumene” belt which contains beryllium in the form of beryllium  
oxide and beryl.(Griffitts, 1954;Kesler, 1942) This two mile wide belt of minerals extends from 
Gaffney, South Carolina toward the northeast. The path goes through the eastern portion of North 
Carolina's Cleveland county, the northwest section of Gaston County, and ends in the south 
central portion of Lincoln County.  About 40,000 tons of beryl (~12% BeO) are thought to be 
contained in the minable spodumene ore of Kings Mountain and another 238,000 tons of beryl in
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other pegmatite in the area.  The Beaverdam portion of the belt which is located further north in 
Gaston county has about 6,000 tons of beryl and a little over twice that amount in other parts of 
the Beaverdam area.  
 The proximity of the neighborhood sarcoidosis cases to environmental beryllium 
introduces the possibility that these neighborhood sarcoidosis cases might possibly be cases of 
berylliosis rather than sarcoidosis.  Sarcoidosis and berylliosis are difficult to distinguish and 
further study would be needed with the cooperation of these patients.  
 There were 445 deaths attributed to sarcoidosis in North Carolina over the years 2005-
2009. (State Center for Health Statistics, NC DHHS 2005-2009, raw data contributed by Dr 
Ricky Langley).  There was one North Carolina death attributed to berylliosis during this same 
period.  Of North Carolina's 100 counties, 78 counties reported sarcoidosis deaths during this 5 
year span and 22 counties did not.  Of those counties that reported sarcoidosis deaths, the total 
number of deaths ranged from 1 to 31.  
 Since the counties having larger populations might have a larger number of sarcoidosis 
cases to report based on their population alone, a death rate was considered a more appropriate 
statistic. The previously mentioned death totals were used along with the population estimates 
for each county (North Carolina Revised Population Estimates, 2005-2009) summed over the 
years 2005-2009 to obtain a death rate.  The rate of death due to sarcoidosis in North Carolina 
counties ranged from 1.1 to 53.9 sarcoidosis deaths per million county residents with a mean 
death rate of 13.5.  The highest rate (53.9) was in Chowan County in northeastern North 
Carolina. The next 5 highest rates were Hertford (41.5), Bertie (38.9), Nash (31.7), Halifax 
(29.0), and Bladen (28.9).  Three of the counties having the highest rates, Chowan, Hertford, and 
Bertie are clustered together in the northeastern part of North Carolina.   
  Cleveland County which had the cluster of sarcoidosis cases which were being 
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 Figure 2:  NC Death Rates per County; plotted using R(RCoreTeam, 2013;Brownrigg et               
al.(R version), 2013) 
 
considered as possible berylliosis cases had a rate of 16.6 sarcoidosis deaths per million 
residents. The one North Carolina death attributed to berylliosis occurred in Gaston county 
which is adjacent to Cleveland County. 
Even though Cleveland County, North Carolina and the surrounding area has a large 
beryllium reserve, minerals other than beryllium rather than beryllium itself are currently mined 
there. It is not known whether locations which are actually involved in mining beryllium might 
have an elevated sarcoidosis death rate in the local populations either as a consequence of the 
mining or due to the types of soil in the region.     
Utah is one of the states which has been involved in beryllium mining for years, but it is 
not known whether there was increased sarcoidosis deaths due to mining.  The website 
http://www.us-mining.com/utah/beryllium-mines was useful in identifying some of the Utah 
counties engaged in beryllium mining.  When Utah’s Mortality ICD-10 module 
(ibis.health.utah.gov) was queried for counties reporting sarcoidosis (ICD code -D86) during 
years 2008-2012 there were several Utah counties listed as having deaths.  Only 4 counties had 
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reportable counts, and they included the mining counties Davis (5), Tooele (4), Utah (4) and an 
urban county Salt Lake (11).  These values were reported to have coefficients of variation of 
greater than 30% by the Utah query module.  Counties which were listed in the query response as 
having sarcoidosis deaths but had suppressed counts due to relative standard error of greater than 
50% were Box Elder, Duchesne, Uintah, and Washington.   The sarcoidosis deaths for Davis, 
Tooele, and Utah were adjusted for population to get a sarcoidosis death rate and then compared 
to a nonberyllium mining county, Salt Lake, see Figure 3. 
                                                         
 
        Figure 3. Utah Sarcoidosis Deaths per Million Residents 
 
It is obvious that Tooele County which is located just north of the Spor Mountain area 
(Juab County) has a higher sarcoidosis rate than those of other counties. It is not known whether 
this would be due to the mining in the area since other mining counties (Davis and Utah) did not 
show elevated sarcoidosis deaths compared to an urban county (Salt Lake). There were no 
berylliosis cases reported in the Utah Ibis module for the years 2008-2012.  
 The CDC Wonder Compressed Mortality data (http://wonder.cdc.gov) for sarcoidosis of 
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all types (ICD code D86) revealed that there were 10,348 deaths reported in years 1999-2010. 
CDC’s query report includes a crude rate per 100,000 population for search topics. The death rate 
per 100,000 for blacks during these years was 1.3 (6285 deaths) and the rate for whites was 0.1 
(3,984 deaths). American Indian or Alaska Natives had a low rate based on a total of 20 deaths 
and Asian and Pacific Islanders had a total of 23 deaths during this time.  
 A similar query of CDC Wonder Compressed Mortality data for berylliosis revealed a 
total of 81 berylliosis deaths (ICD code J63.2) during the years 1999-2010.  79 of those deaths 
were individuals of the white race.  The race(s) of the other two individuals was not specified. 
The states having the most deaths were Ohio with 16 and Pennsylvania with 21. The states 
making up the remainder of the deaths were not identified.
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Chapter 3: Discussion 
 Berylliosis shares common characteristics with other lung diseases, most notably 
sarcoidosis.  This literature review has included many of the basic characteristics of both 
berylliosis and sarcoidosis as well as some of their distinctions.  
 This project initially had the objective of evaluating individual(s) from a neighborhood 
cluster of sarcoidosis cases for evidence of berylliosis.  The justification for suggesting their 
diagnosis could be berylliosis was based in part on the clinical similarity of sarcoidosis and 
berylliosis, and the fact that the quarry region has one of the highest beryllium reserves in the 
U.S. (Bentzen, 1970) Additionally, the quarry was located a few miles away from the 
neighborhood in which the quarry worker and several other people lived who had been 
diagnosed with sarcoidosis.  The gravel from local quarries had been used on some of the 
neighborhood roads before they were paved and thus may have contributed to environmental 
exposure.  Since there were nonquarry workers and multiple households which were affected 
further investigation of beryllium as the possible causative agent of the respiratory disease would 
include the rationale that this was an environmental exposure and not just an occupational 
exposure.  
 The sarcoidosis patients in this cluster were diagnosed many years ago.  Their lung 
biopsy samples had been stored at local hospitals, and it was thought that with the cooperation of 
the patients, their paraffin embedded tissues might be analyzed for the presence of beryllium.       
However, upon re-initiating communications with these patients, and focusing on the most likely 
and cooperative candidate for beryllium exposure, the quarry worker, we found that the hospital
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 did not retain the tissue samples long enough for us to carry out this analysis. 
 Once it became clear that the tissue sample from the most likely candidate for the 
detection of beryllium was not available, it became necessary to rethink this project.  An 
alternative solution that could have been pursued would have been to obtain fresh blood samples 
from patients and to have those blood samples analyzed by beryllium lymphocyte proliferation 
testing (BLPT).  A positive BLPT would tell us the patient had been sensitized by beryllium, but 
a negative test would not necessarily indicate that the patient had not had an environmental 
exposure.  Only a small percentage of patients who are exposed to beryllium become sensitized 
and /or develop berylliosis.  A positive BLPT test; however, would excluded sarcoidosis as a 
diagnosis; patients suffering from granulomatous diseases other than berylliosis have not 
produced positive BLPT tests, i.e. the BLPT test has high specificity albeit with a sensitivity that 
has been reported to vary from low to high levels. (Muller-Quernheim, 2005)  The BLPT had 
been considered early in the project and had been projected to be used as a confirmation test if 
and when detection of beryllium by analytical means had been achieved. 
 The cluster which occurred in Cleveland County is still only a small group of diagnosed 
sarcoidosis individuals, but the occurrence is west of the North Carolina areas associated with 
the highest death rates according to the data in Figure 2 and also according to the World War II 
era study which developed associations between sarcoidosis and soil type, induction location, 
and the Fall Line depicting the majority of the cases.(Gentry et al., 1955) 
 Older reports of sarcoidosis in the western states indicate that it is not a very common 
disease in that part of the country.(Beier & Lahey, 1964)  Part of their stated reasoning for 
considering it uncommon  was that among birthplaces determined during 2 studies of military 
servicemen with sarcoidosis, one with 400 Army personnel from 1952-1956 and the other a 
Navy and Marines study which included 132 servicemen from 1957-1958, showed that none of 
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the study individuals had originated from Utah.(Cooch, 1961;Gundelfinger, B.F. & Britten, 
1961). Although the Beier & Lahey publication reported on 8 white children with sarcoidosis  
over a 7 year period during that era, it seems that current data also indicates that sarcoidosis 
remains uncommon there.   The increased death rate in Tooele County may be an indication of 
higher incidence due to mining activity or there could be other unknown reasons. However, the 
sarcoidosis death rate in a known beryllium mining area such as in Tooele County is lower than 
many of the death rates seen in North Carolina for sarcodosis regardless of mining activities.  
  Further study of chronic beryllium disease and sarcoidosis could proceed in at least two 
additional directions.  One direction would be to determine whether there is hospitalization 
information for sarcoidosis and/or berylliosis that might help further explain any patterns of 
sarcoidosis/berylliosis occurring in North Carolina and yet are not well-defined or obvious even 
when the death rates are considered.  One of the most obvious conclusions and one of the most 
obvious reasons for adding this step is that sarcoidosis death rates might not correlate well with 
the number of sarcoidosis cases.  The analysis of in-patient hospitalizations for sarcoidosis (or 
berylliosis) could add more detail or perhaps provide a more accurate representation of these 
diseases.  This approach of using in-patient hospitalization data was the basis of a study of North 
Carolina asbestosis and silicosis cases, and among many findings the research revealed that the 
highest silicosis rates were in Western North Carolina and that asbestosis cases did not show a 
geographical pattern. (Dang, et al., 2013) 
 An introductory look into available resources shows that the University of North Carolina 
Sheps Center provides a NC Discharge database, but according to their website 
(http://www.shepscenter.unc.edu/data) these are not public records.  Access to their information 
requires an application, and among the requirements are IRB permission or IRB exemption 
information.  To access more general data the UNC Sheps Center recommends HCUPnet, a free, 
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searchable service, see website http://hcupnet.ahrq.gov/.  The HCUP site includes searchable 
state data that can be used to determine the number of sarcoidosis discharges (ICD-9, code 135) 
in a given year, but the site for North Carolina does not provide county specific information 
using ICD codes.  The HCUP site state searches can provide hospital stay/discharge information 
for a primary diagnosis such as sarcoidosis in terms of age, gender, and metropolitan vs suburban 
type areas as well as many other possibilities.  The site does have a beta system with some 
county information searchable by Clinical Classification Software which groups numerous ICD 
codes into a category rather than by ICD code.  In order to develop a North Carolina County map 
of sarcoidosis discharge rates further research would be needed.   
  The other major research direction which could be taken to further the understanding of 
the sarcoidosis/berylliosis cases would be to look at environmental factors in the area of the 
beryllium deposits by environmental sampling.  Soil samples from Cleveland County or other 
counties of interest could be analyzed for respirable silica and beryllium content to determine 
whether levels of these minerals correlate with sarcoidosis/berylliosis deaths and/or 
hospitalizations from the county.  A study in which soil metals levels were being evaluated for 
possible correlation with elevated levels of mental retardation and developmental delay did not 
show any significant beryllium concentration  differences in any regions including control 
regions for the study.(Aelion et al., 2009) While this study did not contribute to understanding of 
berylliosis and sarcoidosis it does provide soil sampling techniques and laboratory information 
that would be useful.  For the soil study 20-50 mg of the top 5 cm of soil from each study 
location was collected and then sent to Pace Analytical Lab in Huntersville, North Carolina.  It 
appears as though the sample collection requirement and the analysis lab would both be 
convenient for further study of Cleveland County soils. 
 A study of air concentrations of beryllium in areas ranging from rural farming areas to 
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highly industrialized areas of Ohio made use of gas chromatography as a tool for analysis of 
beryllium particulates captured by high volume air samplers.(Ross et al., 1977) Wind blowing 
from industrialized sites toward sites of interest was shown to increase ambient air 
concentrations of beryllium between 1 and 1.5ppm for some locations which had beryllium 
levels ranging approximately 0.7 to 2.8ppm.  Wind was not a factor in some sites, but with 
regard to the Cleveland County study, the wind contribution would introduce an additional 
variable for consideration. 
 Stream water from numerous North Carolina counties has already been mapped to some 
extent for beryllium and other minerals, but some of this beryllium data was documented years 
ago in 1999 (http://www.geology.enr.state.nc.us/NUREgeochem/geochem2.htm). Additional 
sampling and analysis could provide more current information.  
 The best possible study might use all of the above approaches to provide a 
comprehensive overview of sarcoidosis and berylliosis using clinical, epidemiological, and 
environmental data.  These data could provide better understanding of the impact of a 
geographically enriched beryllium environment on health and possibly help identify 
environmental conditions which contribute to beryllosis or sarcoidosis.  
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APPENDIX 
Table 1:  North Carolina County Death Rates from Sarcoidosis 
County Estimated 
Population 2005-
2009 
Total Number of 
Sarcoidosis Deaths 
2005-2009 
Sarcoidosis 
Deaths/Total 
Population (x 10 
-6
) 
Alamance 717.789 2 2.8 
Alexander 181,783 2 11.0 
Alleghany 54,751 NA NA 
Anson 133,118 2 15.0 
Ashe 131,612 1 7.6 
Avery 89,399 NA NA 
Beaufort 231,31 2 8.7 
Bertie 102,848 4 38.9 
Bladen 173,142 5 28.9 
Brunswick 487,853 3 6.2 
Buncombe 1,142,531 4 3.5 
Burke 446,347 1 2.2 
Cabarrus 817,427 5 6.1 
Caldwell 405,374 2 4.9 
Camden 47,763 NA NA 
Carteret 321,538 4 12.4 
Caswell 118,358 1 8.5 
Catawba 751,343 3 4.0 
Chatham 296,465 6 20.2 
Cherokee 134,178 NA NA 
Chowan 74,216 4 53.9 
Clay 50.806 1 19.7 
Cleveland 482,079 8 16.6 
Columbus 280,713 3 10.7 
Craven 492,574 5 10.2 
Cumberland 1,546,060 26 16.8 
Currituck 116,159 1 8.6 
Dare 171,115 NA NA 
Davidson 788,335 7 8.9 
Davie 198,123 1 5.1 
Duplin 279,123 5 17.9 
Durham 1,261,033 20 15.9 
Edgecombe 277,868 4 14.4 
Forsyth 1,682,774 22 13.1 
Franklin 284,102 1 3.5 
Gaston 994,251 6 6.0 
Gates 59480 1 16.8 
Graham 42591 NA NA 
Granville 285,217 NA NA 
Greene 103,327 2 19.4 
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County Estimated 
Population 2005-
2009 
Total Number of 
Sarcoidosis Deaths 
2005-2009 
Sarcoidosis 
Deaths/Total 
Population (x 10 
-6
) 
Guilford 2,320,439 27 11.6 
Halifax 276,228 8 29.0 
Harnett 528,368 9 17.0 
Haywood 335,371 1 3.0 
Henderson 509,055 2 3.9 
Hertford 120,410 5 41.5 
Hoke 218,007 4 18.3 
Hyde 29,053 NA NA 
Iredell 747,823 4 5.4 
Jackson 190,923 1 5.2 
Johnston 772,729 8 10.4 
Jones 50,510 NA NA 
Lee 276,846 3 10.8 
Lenoir 296,660 7 23.6 
Lincoln 367,956 NA NA 
Macon 165,307 NA NA 
Madison 101,649 NA NA 
Martin 122,618 1 8.2 
McDowell 220,515 2 9.1 
Mecklenburg 4,306,279 31 7.2 
Mitchell 77,589 NA NA 
Montgomery 137,221 NA NA 
Moore 420,309 6 14.3 
Nash 378,993 12 31.7 
New Hanover 966,440 8 8.3 
Northampton 109,664 3 27.4 
Onslow 849,419 4 4.7 
Orange 636,283 1 1.6 
Pamlico 65,386 1 15.3 
Pasquotank 198,549 4 20.1 
Pender 243,020 3 12.3 
Perquimans 64228 NA NA 
Person 190640 3 15.7 
Pitt 779,691 13 16.7 
Polk 99,056 NA NA 
Randolph 688,682 4 5.8 
Richmond 232,046 2 8.6 
Robeson 651,916 16 24.5 
Rockingham 462,614 6 13.0 
Rowan 672,395 6 8.9 
Rutherford 328,965 3 9.1 
Sampson 313,022 7 22.4 
Scotland 181,313 5 27.6 
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County Estimated 
Population 2005-
2009 
Total Number of 
Sarcoidosis Deaths 
2005-2009 
Sarcoidosis 
Deaths/Total 
Population (x 10 
-6
) 
Stanly 296,693 2 6.74 
Stokes 232,977 1 4.3 
Surry 363,116 3 8.3 
Swain 69,114 NA NA 
Transylvania 159,172 4 25.1 
Tyrell 21,764 NA NA 
Union 904,281 1 1.1 
Vance 223,837 3 13.4 
Wake 4,101,779 28 6.8 
Warren 103,200 NA NA 
Wayne 596,220 9 15.1 
Wilkes 340,694 NA NA 
Wilson 392,731 10 25.5 
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Figure 4:  Spodumene-Tin Belt and Other Mineral Regions (Griffitts, 1954) 
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Figure 5: North Carolina Counties (RCoreTeam, 2013;Brownrigg et al (R version), 2013) 
 
 
